JAMES BRYANT HALL II
JAMES BRYANT HALL II is named as a lobbyist in 19 lobbying reports we hold, filed by 1 registrant for 19 clients.
Earlier government jobs, as reported
A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.
- Staff Director, Senate Veterans Affairs Committee; Legislative Director, Senator Bob Graham
Registrants and clients
- B HALL STRATEGIES, LLC · 19 reports
Clients: TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCE; TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS; TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.; TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.; TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.; TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.; TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS; TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.; TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC.; TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC; TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION; TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.; TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA; TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.; TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY; TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.; TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC; TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS; TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA.
Bills named where this lobbyist is listed, and how the House and the Senate voted
2 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 842Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act | Reported by committee | No recorded vote in our record |
| H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act | Introduced | No recorded vote in our record |
Issues named: Pharmacy (13), Medicare/Medicaid (5), Health Issues (1).
Every report
| Client | Registrant | Kind, as filed | Posted | Report |
|---|---|---|---|---|
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMAPharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTISPharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLCMedicare/Medicaid | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.Pharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANYPharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.Pharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICAMedicare/Medicaid | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.Pharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATIONPharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF ORGANON, LLCPharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC.Medicare/Medicaid | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.Pharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALSMedicare/Medicaid | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.Pharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.Pharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.Pharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.Pharmacy | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP OBO SIEMENS HEALTHINEERSMedicare/Medicaid | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov | |
| TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCEHealth Issues | B HALL STRATEGIES, LLC | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this lobbyist reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.